-
1
-
-
40949147326
-
Quality of life and satisfaction with outcome among prostate-cancer survivors
-
Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358:1250- 1261.
-
(2008)
N Engl J Med
, vol.358
, pp. 1250-1261
-
-
Sanda, M.G.1
Dunn, R.L.2
Michalski, J.3
-
2
-
-
84864008031
-
Radical prostatectomy versus observation for localized prostate cancer
-
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203-213.
-
(2012)
N Engl J Med
, vol.367
, pp. 203-213
-
-
Wilt, T.J.1
Brawer, M.K.2
Jones, K.M.3
-
3
-
-
84864486220
-
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy
-
Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012; 62:405-417.
-
(2012)
Eur Urol
, vol.62
, pp. 405-417
-
-
Ficarra, V.1
Novara, G.2
Rosen, R.C.3
-
4
-
-
84918513255
-
Impact of family history on prostate cancer mortality in caucasian men undergoing PSA-based screening
-
Epub ahead of print
-
Liss MA, Chen H, Hemal S, et al. Impact of family history on prostate cancer mortality in caucasian men undergoing PSA-based screening. J Urol 2014. [Epub ahead of print].
-
(2014)
J Urol
-
-
Liss, M.A.1
Chen, H.2
Hemal, S.3
-
5
-
-
84880005911
-
Early detection of prostate cancer: AUA guideline
-
Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol 2013; 190:419-426.
-
(2013)
J Urol
, vol.190
, pp. 419-426
-
-
Carter, H.B.1
Albertsen, P.C.2
Barry, M.J.3
-
7
-
-
0032974501
-
Genetic predisposition to prostate cancer
-
Eeles RA. Genetic predisposition to prostate cancer. Prostate Cancer Prostatic Dis 1999; 2:9-15.
-
(1999)
Prostate Cancer Prostatic Dis
, vol.2
, pp. 9-15
-
-
Eeles, R.A.1
-
9
-
-
0037635390
-
A systematic review and meta-analysis of familial prostate cancer risk
-
Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003; 91:789-794.
-
(2003)
BJU Int
, vol.91
, pp. 789-794
-
-
Johns, L.E.1
Houlston, R.S.2
-
10
-
-
84858809529
-
Genetic variants associated with predisposition to prostate cancer and potential clinical implications
-
Goh CL, Schumacher FR, Easton D, et al. Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med 2012; 271:353-365.
-
(2012)
J Intern Med
, vol.271
, pp. 353-365
-
-
Goh, C.L.1
Schumacher, F.R.2
Easton, D.3
-
11
-
-
0034644185
-
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from sweden, denmark, and Finland
-
Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78-85.
-
(2000)
N Engl J Med
, vol.343
, pp. 78-85
-
-
Lichtenstein, P.1
Holm, N.V.2
Verkasalo, P.K.3
-
12
-
-
84860870211
-
Inherited susceptibility for aggressive prostate cancer
-
Isaacs WB. Inherited susceptibility for aggressive prostate cancer. Asian J Androl 2012; 14:415-418.
-
(2012)
Asian J Androl
, vol.14
, pp. 415-418
-
-
Isaacs, W.B.1
-
13
-
-
79956068299
-
National cancer institute prostate cancer genetics workshop
-
Catalona WJ, Bailey-Wilson JE, Camp NJ, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res 2011; 71:3442-3446.
-
(2011)
Cancer Res
, vol.71
, pp. 3442-3446
-
-
Catalona, W.J.1
Bailey-Wilson, J.E.2
Camp, N.J.3
-
14
-
-
84865693861
-
The role of genetic markers in the management of prostate cancer
-
Choudhury AD, Eeles R, Freedland SJ, et al. The role of genetic markers in the management of prostate cancer. Eur Urol 2012; 62:577-587.
-
(2012)
Eur Urol
, vol.62
, pp. 577-587
-
-
Choudhury, A.D.1
Eeles, R.2
Freedland, S.J.3
-
15
-
-
0035094764
-
Variation is the spice of life
-
Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001; 27:234-236.
-
(2001)
Nat Genet
, vol.27
, pp. 234-236
-
-
Kruglyak, L.1
Nickerson, D.A.2
-
16
-
-
84875739291
-
Identification of 23 new prostate cancer susceptibility loci using the ICOGS custom genotyping array
-
Eeles RA, Olama AA, Benlloch S, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013; 45:385-391.
-
(2013)
Nat Genet
, vol.45
, pp. 385-391
-
-
Eeles, R.A.1
Olama, A.A.2
Benlloch, S.3
-
17
-
-
84893759915
-
The genetic epidemiology of prostate cancer and its clinical implications
-
Eeles R, Goh C, Castro E, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol 2014; 11:18-31.
-
(2014)
Nat Rev Urol
, vol.11
, pp. 18-31
-
-
Eeles, R.1
Goh, C.2
Castro, E.3
-
18
-
-
40049098166
-
Cumulative association of five genetic variants with prostate cancer
-
Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358:910-919.
-
(2008)
N Engl J Med
, vol.358
, pp. 910-919
-
-
Zheng, S.L.1
Sun, J.2
Wiklund, F.3
-
19
-
-
69449098701
-
Estimation of absolute risk for prostate cancer using genetic markers and family history
-
Xu J, Sun J, Kader AK, et al. Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 2009; 69:1565-1572.
-
(2009)
Prostate
, vol.69
, pp. 1565-1572
-
-
Xu, J.1
Sun, J.2
Kader, A.K.3
-
20
-
-
54049139306
-
Multiple novel prostate cancer predisposition loci confirmed by an international study: The PRACTICAL consortium
-
Kote-Jarai Z, Easton DF, Stanford JL, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: The PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 2008; 17:2052-2061.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 2052-2061
-
-
Kote-Jarai, Z.1
Easton, D.F.2
Stanford, J.L.3
-
21
-
-
84859386051
-
Common genetic variants in prostate cancer risk prediction - results from the NCI breast and prostate cancer cohort consortium (BPC3)
-
Lindstrom S, Schumacher FR, Cox D, et al. Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2012; 21:437-444.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 437-444
-
-
Lindstrom, S.1
Schumacher, F.R.2
Cox, D.3
-
22
-
-
67650609664
-
Individual and cumulative effect of prostate cancer risk-associated variants on clinic pathologic variables in 5, 895 prostate cancer patients
-
Kader AK, Sun J, Isaacs SD, et al. Individual and cumulative effect of prostate cancer risk-associated variants on clinic pathologic variables in 5, 895 prostate cancer patients. Prostate 2009; 69:1195-1205.
-
(2009)
Prostate
, vol.69
, pp. 1195-1205
-
-
Kader, A.K.1
Sun, J.2
Isaacs, S.D.3
-
23
-
-
84868599480
-
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial
-
Kader AK, Sun J, Reck BH, et al. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. Eur Urol 2012; 62:953-961.
-
(2012)
Eur Urol
, vol.62
, pp. 953-961
-
-
Kader, A.K.1
Sun, J.2
Reck, B.H.3
-
24
-
-
81155161807
-
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men
-
Liu F, Hsing AW, Wang X, et al. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci 2011; 102:1916-1920.
-
(2011)
Cancer Sci
, vol.102
, pp. 1916-1920
-
-
Liu, F.1
Hsing, A.W.2
Wang, X.3
-
25
-
-
84859083855
-
A comparison of bayesian and Frequentist approaches to incorporating external information for the prediction of prostate cancer risk
-
Newcombe PJ, Reck BH, Sun J, et al. A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk. Genet Epidemiol 2012; 36:71-83.
-
(2012)
Genet Epidemiol
, vol.36
, pp. 71-83
-
-
Newcombe, P.J.1
Reck, B.H.2
Sun, J.3
-
26
-
-
78650468754
-
Genetic correction of PSA values using sequence variants associated with PSA levels
-
Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2010; 2:62ra92.
-
(2010)
Sci Transl Med
, vol.2
, pp. 62ra92
-
-
Gudmundsson, J.1
Besenbacher, S.2
Sulem, P.3
-
27
-
-
84876295479
-
Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies
-
Helfand BT, Loeb S, Hu Q, et al. Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies. J Urol 2013; 189:1697-1701.
-
(2013)
J Urol
, vol.189
, pp. 1697-1701
-
-
Helfand, B.T.1
Loeb, S.2
Hu, Q.3
-
28
-
-
0034454414
-
Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins
-
Bansal A, Murray DK, Wu JT, et al. Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins. J Clin Endocrinol Metab 2000; 85:1272-1276.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 1272-1276
-
-
Bansal, A.1
Murray, D.K.2
Wu, J.T.3
-
29
-
-
33748039452
-
Heritability of cardiovascular and personality traits in 6, 148 Sardinians
-
Pilia G, Chen WM, Scuteri A, et al. Heritability of cardiovascular and personality traits in 6, 148 Sardinians. PLoS Genet 2006; 2:e132.
-
(2006)
PLoS Genet
, vol.2
, pp. e132
-
-
Pilia, G.1
Chen, W.M.2
Scuteri, A.3
-
30
-
-
79956109375
-
Germ line sequence variants and prostate-specific antigen interpretation
-
Loeb S. Germ line sequence variants and prostate-specific antigen interpretation. Clin Chem 2011; 57:662-663.
-
(2011)
Clin Chem
, vol.57
, pp. 662-663
-
-
Loeb, S.1
-
31
-
-
67349141550
-
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level
-
discussion 105
-
Loeb S, Carter HB, Walsh PC, et al. Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level. J Urol 2009; 182:101-104; discussion 105.
-
(2009)
J Urol
, vol.182
, pp. 101-104
-
-
Loeb, S.1
Carter, H.B.2
Walsh, P.C.3
-
32
-
-
69449103575
-
Identification of new genetic risk factors for prostate cancer
-
Guy M, Kote-Jarai Z, Giles GG, et al. Identification of new genetic risk factors for prostate cancer. Asian J Androl 2009; 11:49-55.
-
(2009)
Asian J Androl
, vol.11
, pp. 49-55
-
-
Guy, M.1
Kote-Jarai, Z.2
Giles, G.G.3
-
33
-
-
33751261645
-
Variants of the HK2 protein gene (KLK2) are associated with serum HK2 levels and predict the presence of prostate cancer at biopsy
-
Nam RK, Zhang WW, Klotz LH, et al. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. Clin Cancer Res 2006; 12:6452-6458.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6452-6458
-
-
Nam, R.K.1
Zhang, W.W.2
Klotz, L.H.3
-
34
-
-
78650595744
-
Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer
-
Kohli M, Rothberg PG, Feng C, et al. Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer. Cancer Bio mark 2010; 7:101-108.
-
(2010)
Cancer Bio Mark
, vol.7
, pp. 101-108
-
-
Kohli, M.1
Rothberg, P.G.2
Feng, C.3
-
35
-
-
84879462937
-
Common variation in kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness
-
Lose F, Batra J, O'Mara T, et al. Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urol Oncol 2013; 31:635-643.
-
(2013)
Urol Oncol
, vol.31
, pp. 635-643
-
-
Lose, F.1
Batra, J.2
O'Mara, T.3
-
36
-
-
79955805321
-
Association of prostate cancer risk loci with disease aggressiveness and prostate cancer-specific mortality
-
Pomerantz MM, Werner L, Xie W, et al. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Cancer Prev Res (Phila) 2011; 4:719-728.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 719-728
-
-
Pomerantz, M.M.1
Werner, L.2
Xie, W.3
-
37
-
-
84873047405
-
Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA
-
Jin G, Zheng SL, Lilja H, et al. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA. Neoplasia 2013; 15:95-101.
-
(2013)
Neoplasia
, vol.15
, pp. 95-101
-
-
Jin, G.1
Zheng, S.L.2
Lilja, H.3
-
38
-
-
77952026425
-
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: Kallikreins and prostate cancer
-
Klein RJ, Hallden C, Cronin AM, et al. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer Prev Res (Phila) 2010; 3:611-619.
-
(2010)
Cancer Prev Res (Phila)
, vol.3
, pp. 611-619
-
-
Klein, R.J.1
Hallden, C.2
Cronin, A.M.3
-
39
-
-
84876467954
-
Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels pros tate specific antigen (PSA) in a chinese population
-
Sun J, Tao S, Gao Y, et al. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels pros tate specific antigen (PSA) in a Chinese population. Hum Genet 2013; 132:423- 429.
-
(2013)
Hum Genet
, vol.132
, pp. 423-429
-
-
Sun, J.1
Tao, S.2
Gao, Y.3
-
40
-
-
84905585602
-
A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population
-
Terao C, Terada N, Matsuo K, et al. A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population. J Med Genet 2014; 51:530-536.
-
(2014)
J Med Genet
, vol.51
, pp. 530-536
-
-
Terao, C.1
Terada, N.2
Matsuo, K.3
-
41
-
-
77953688557
-
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: An independent replication
-
Vickers A, Cronin A, Roobol M, et al. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: An independent replication. J Clin Oncol 2010; 28:2493-2498.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2493-2498
-
-
Vickers, A.1
Cronin, A.2
Roobol, M.3
-
42
-
-
77953715079
-
A four-kallikrein panel predicts prostate cancer in men with recent screening: Data from the European randomized study of screening for prostate cancer, Rotterdam
-
Vickers AJ, Cronin AM, Roobol MJ, et al. A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam. Clin Cancer Res 2010; 16:3232-3239.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3232-3239
-
-
Vickers, A.J.1
Cronin, A.M.2
Roobol, M.J.3
-
43
-
-
84979850523
-
Genetically-adjusted PSA values may prevent delayed biopsies in African-American men
-
Donin N, Loeb S, Cooper PR, et al. Genetically-adjusted PSA values may prevent delayed biopsies in African-American men. BJU Int 2014.
-
(2014)
BJU Int
-
-
Donin, N.1
Loeb, S.2
Cooper, P.R.3
-
44
-
-
60349091551
-
Prostate cancer disparities in black men of African descent: A comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa
-
Odedina FT, Akinremi TO, Chinegwundoh F, et al. Prostate cancer disparities in Black men of African descent: A comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 2009; 4 (Suppl 1):S2.
-
(2009)
Infect Agent Cancer
, vol.4
, pp. S2
-
-
Odedina, F.T.1
Akinremi, T.O.2
Chinegwundoh, F.3
-
45
-
-
58149461559
-
Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities
-
Williams H, Powell IJ. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol 2009; 472:439-453.
-
(2009)
Methods Mol Biol
, vol.472
, pp. 439-453
-
-
Williams, H.1
Powell, I.J.2
-
46
-
-
1642372310
-
The effect of race/ethnicity on prostate cancer treatment outcome is conditional: A review of Wayne state university data
-
Powell IJ, Banerjee M, Bianco FJ, et al. The effect of race/ethnicity on prostate cancer treatment outcome is conditional: A review of Wayne State University data. J Urol 2004; 171:1508-1512.
-
(2004)
J Urol
, vol.171
, pp. 1508-1512
-
-
Powell, I.J.1
Banerjee, M.2
Bianco, F.J.3
-
47
-
-
79961241801
-
A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies
-
Ishak MB, Giri VN. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies. Cancer Epidemiol Biomarkers Prev 2011; 20:1599-1610.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 1599-1610
-
-
Ishak, M.B.1
Giri, V.N.2
-
48
-
-
84876150925
-
Prostate cancer: Improving PSA testing by adjusting for genetic background
-
Scardino PT. Prostate cancer: Improving PSA testing by adjusting for genetic background. Nat Rev Urol 2013; 10:190-192.
-
(2013)
Nat Rev Urol
, vol.10
, pp. 190-192
-
-
Scardino, P.T.1
-
49
-
-
66149110014
-
A novel prostate cancer susceptibility locus at 19q13
-
Hsu FC, Sun J, Wiklund F, et al. A novel prostate cancer susceptibility locus at 19q13. Cancer Res 2009; 69:2720-2723.
-
(2009)
Cancer Res
, vol.69
, pp. 2720-2723
-
-
Hsu, F.C.1
Sun, J.2
Wiklund, F.3
-
50
-
-
84455194547
-
Early onset prostate cancer has a significant genetic component
-
Lange EM, Salinas CA, Zuhlke KA, et al. Early onset prostate cancer has a significant genetic component. Prostate 2012; 72:147-156.
-
(2012)
Prostate
, vol.72
, pp. 147-156
-
-
Lange, E.M.1
Salinas, C.A.2
Zuhlke, K.A.3
-
51
-
-
35448976941
-
Tagging SNPS in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin
-
Pal P, Xi H, Sun G, et al. Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum Genet 2007; 122:251-259.
-
(2007)
Hum Genet
, vol.122
, pp. 251-259
-
-
Pal, P.1
Xi, H.2
Sun, G.3
-
52
-
-
84870550463
-
Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1, 536 GWAS and candidate SNPS in African-Americans and European-Americans
-
Bensen JT, Xu Z, Smith GJ, et al. Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1, 536 GWAS and candidate SNPs in African-Americans and European-Americans. Prostate 2013; 73:11-22.
-
(2013)
Prostate
, vol.73
, pp. 11-22
-
-
Bensen, J.T.1
Xu, Z.2
Smith, G.J.3
-
53
-
-
84897029609
-
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?
-
Cormio L, Scattoni V, Lorusso F, et al. Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? JT World J Urol. 2014; 32:341-346.
-
(2014)
JT World J Urol
, vol.32
, pp. 341-346
-
-
Cormio, L.1
Scattoni, V.2
Lorusso, F.3
-
54
-
-
84886946836
-
Plateau effect of prostate cancer risk-associated SNPS in discriminating prostate biopsy outcomes
-
Ren S, Xu J, Zhou T, et al. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. Prostate 2013; 73:1824- 1835.
-
(2013)
Prostate
, vol.73
, pp. 1824-1835
-
-
Ren, S.1
Xu, J.2
Zhou, T.3
-
55
-
-
79957946061
-
Polygenic risk score improves prostate cancer risk prediction: Results from the stockholm-1 cohort study
-
Aly M, Wiklund F, Xu J, et al. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol 2011; 60:21-28.
-
(2011)
Eur Urol
, vol.60
, pp. 21-28
-
-
Aly, M.1
Wiklund, F.2
Xu, J.3
-
56
-
-
84867389238
-
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese
-
Akamatsu S, Takahashi A, Takata R, et al. Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese. PLoS One 2012; 7:e46454.
-
(2012)
PLoS One
, vol.7
, pp. e46454
-
-
Akamatsu, S.1
Takahashi, A.2
Takata, R.3
-
57
-
-
84884910670
-
Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPS
-
Jiang H, Liu F, Wang Z, et al. Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs. Prostate 2013; 73:1651-1659.
-
(2013)
Prostate
, vol.73
, pp. 1651-1659
-
-
Jiang, H.1
Liu, F.2
Wang, Z.3
-
58
-
-
79953693893
-
GWAS SNP replication among African American and European American men in the north Carolina-Louisiana prostate cancer project (PCAP)
-
Xu Z, Bensen JT, Smith GJ, et al. GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate 2011; 71:881-891.
-
(2011)
Prostate
, vol.71
, pp. 881-891
-
-
Xu, Z.1
Bensen, J.T.2
Smith, G.J.3
-
59
-
-
77950498003
-
Effect of dutasteride on the risk of prostate cancer
-
Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010; 362:1192-1202.
-
(2010)
N Engl J Med
, vol.362
, pp. 1192-1202
-
-
Andriole, G.L.1
Bostwick, D.G.2
Brawley, O.W.3
-
60
-
-
84872918220
-
Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history
-
Sun J, Na R, Hsu FC, et al. Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history. Eur Urol 2013; 63:585-587.
-
(2013)
Eur Urol
, vol.63
, pp. 585-587
-
-
Sun, J.1
Na, R.2
Hsu, F.C.3
-
61
-
-
0036569945
-
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors
-
de Kok JB, Verhaegh GW, Roelofs RW, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002; 62:2695- 2698.
-
(2002)
Cancer Res
, vol.62
, pp. 2695-2698
-
-
De Kok, J.B.1
Verhaegh, G.W.2
Roelofs, R.W.3
-
62
-
-
40849087631
-
Pca3: A molecular urine assay for predicting prostate biopsy outcome
-
Deras IL, Aubin SM, Blase A, et al. PCA3: A molecular urine assay for predicting prostate biopsy outcome. J Urol 2008; 179:1587-1592.
-
(2008)
J Urol
, vol.179
, pp. 1587-1592
-
-
Deras, I.L.1
Aubin, S.M.2
Blase, A.3
-
63
-
-
84896795915
-
The prostate health index: A new test for the detection of prostate cancer
-
Loeb S, Catalona WJ. The Prostate Health Index: A new test for the detection of prostate cancer. Ther Adv Urol 2014; 6:74-77.
-
(2014)
Ther Adv Urol
, vol.6
, pp. 74-77
-
-
Loeb, S.1
Catalona, W.J.2
|